“Transgene SA said on Tuesday its experimental vaccine showed favorable results in a small mid-stage trial against precancerous cervical lesions, enabling about half of the women given the vaccine to avoid surgery.”

[Read on]

This entry was posted on Tuesday, April 25th, 2006 at 10:00 pm and is filed under General. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.